Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injection Manufacturing: SOP for Ensuring Tamper-Evident Sealing on Syringe Packs – V 2.0

Posted on By

Sterile Injection Manufacturing: SOP for Ensuring Tamper-Evident Sealing on Syringe Packs – V 2.0

Standard Operating Procedure for Ensuring Tamper-Evident Sealing on Syringe Packs


Department Sterile Injection Manufacturing
SOP No. SOP/SIM/198/2025
Supersedes SOP/SIM/198/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To establish a consistent and GMP-compliant procedure for ensuring tamper-evident sealing on syringe packs in order to prevent unauthorized access or contamination, maintain product integrity, and comply with regulatory expectations for injectable packaging.

2. Scope

This SOP is applicable to all tamper-evident sealing

processes of prefilled syringes during the secondary packaging operations at the Sterile Injection Manufacturing facility.

3. Responsibilities

  • Packing Operator: Ensures correct application of tamper-evident seals during packaging.
  • Line Supervisor: Verifies sealing operation and inspects sealing integrity.
  • Quality Assurance (QA): Conducts in-process checks and documents compliance.
  • Engineering: Maintains and calibrates sealing machines.
See also  Packaging: SOP for Final Labeling and Batch Coding of Injectable Vials - V 2.0

4. Accountability

The Head of Production is accountable for the implementation and compliance of this SOP. The Head of QA is accountable for final approval and audit readiness.

5. Procedure

5.1 Receiving and Preliminary Inspection

  1. Receive tamper-evident labels or seals from the warehouse with accompanying CoA.
  2. Check packaging materials for integrity, batch number, and expiry date.
  3. Document receipt in the Tamper Seal Logbook (Annexure-1).

5.2 Verification of Sealing Materials

  1. Verify that the tamper-evident seals match the approved artwork and specifications.
  2. Cross-check the delivery against the packing batch record and Bill of Materials.
  3. Ensure materials are released by QA before usage.

5.3 Machine Setup and Trial Run

  1. Set sealing machine parameters as per validated batch protocol.
  2. Perform a trial run of 10 units; inspect for alignment, adhesion, and legibility.
  3. Get QA clearance for commencing full operation.

5.4 Tamper-Evident Sealing Process

  1. Feed prefilled syringe packs into the automated sealing machine.
  2. Ensure continuous monitoring of label roll placement and adhesive temperature.
  3. Monitor critical parameters such as pressure, dwell time, and seal width.
  4. Replace label rolls immediately upon detecting end-of-roll or misalignment.
See also  Sterile Injectable Manufacturing: SOP for Use of CIP Systems in Cleaning Lyophilizers - V 2.0

5.5 In-Process Inspection

  1. Inspect one unit every 15 minutes for seal placement, tamper visibility, and legibility.
  2. Use a standard checklist (Annexure-2) to document visual checks.
  3. In case of deviation, isolate affected units and notify QA.

5.6 Post-Operation Verification

  1. Ensure all packs in the batch are sealed and intact before transferring to the shipper.
  2. Document reconciliation of tamper seals used versus dispensed in Annexure-3.
  3. Affix line clearance label and have it verified by QA.

5.7 Documentation and Record-Keeping

  1. Maintain the Tamper Seal Logbook (Annexure-1).
  2. Attach in-process inspection records and reconciliation sheets with the BPR.
  3. QA shall review and archive records for traceability.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CoA: Certificate of Analysis
  • BPR: Batch Packing Record

7. Documents

  1. Tamper Seal Logbook – Annexure-1
  2. Visual Inspection Checklist – Annexure-2
  3. Seal Reconciliation Sheet – Annexure-3
See also  Sterile Injectable Manufacturing: SOP for In-Process Visual Inspection of Vials - V 2.0

8. References

  • WHO TRS 986 Annex 2 – GMP for Pharmaceutical Products
  • 21 CFR Part 211 – Current Good Manufacturing Practice
  • ICH Q8 – Pharmaceutical Development

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Tamper Seal Logbook

Date Seal Batch No. Quantity Received Quantity Used Balance Checked By
24/06/2025 TS-PRF-305 10000 9800 200 Sunita Reddy

Annexure-2: Visual Inspection Checklist

Time Seal Intact Proper Placement Operator Initials QA Verified
09:15 Yes Yes Rajesh Kumar Yes

Annexure-3: Seal Reconciliation Sheet

Batch No. Seal Issued Seal Used Balance Returned QA Verified
PF-2025-009 10000 9800 200 Yes

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
10/03/2022 1.0 Initial issue New SOP Head QA
24/06/2025 2.0 Added reconciliation and checklist procedures Annual Review Head QA
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Analytical Method Development: SOP for Particulate Matter Testing by Light Obscuration – V 2.0
Next Post: Delayed CAPA Implementation Due to Ambiguous SOPs: A Regulatory Time Bomb

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version